ArticleJournal of clinical epidemiology2022
Regression discontinuity analysis for pharmacovigilance: statin example reflected trial findings showing little evidence of harm.
Lauren Scott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.